News & Updates
Filter by Specialty:
Methenamine hippurate prevents recurrent UTI in women
Nonantibiotic treatment with methenamine hippurate shows high levels of efficacy in women with a history of recurrent episodes of urinary tract infection (UTI), which is comparable to the current guideline-recommended prophylaxes (ie, long-course, low-dose antibiotics), according to a study.
Methenamine hippurate prevents recurrent UTI in women
29 Mar 2022BP-lowering drugs reduce death in older hypertensive COVID-19 patients
Antecedent use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) among older COVID-19 patients with hypertension results in fewer all-cause deaths, whether in-hospital or shortly after discharge, compared with no antecedent use of renin-angiotensin system inhibitors (RASIs), a study has shown.
BP-lowering drugs reduce death in older hypertensive COVID-19 patients
29 Mar 2022Prepandemic life expectancy rises in older adults, but disability remains constant
Prior to the COVID-19 pandemic, life expectancy at age 70 years has continued to rise across the globe due to reductions in chronic diseases, according to a recent study. However, disability burden persists and indicates the need to improve public health and intervention initiatives to enhance well-being among older adults.
Prepandemic life expectancy rises in older adults, but disability remains constant
28 Mar 2022Death risk higher among older patients likely to delay, miss medical care due to pandemic
Older patients who are strongly likely to delay or miss medical care due to the coronavirus disease 2019 (COVID-19) pandemic are at greater risk of mortality and worse outcomes, a recent study has found.
Death risk higher among older patients likely to delay, miss medical care due to pandemic
25 Mar 2022Dementia worsens COVID-19 outcomes in community-dwelling older adults
Dementia is an important risk factor for coronavirus disease 2019 (COVID-19) outcomes in community-dwelling older adults, with its effect becoming stronger with increasing patient age, a recent study has found.
Dementia worsens COVID-19 outcomes in community-dwelling older adults
24 Mar 2022Sotrovimab reduces hospitalization, death in patients with COVID-19 regardless of serostatus
Treatment with sotrovimab reduces the risk of all-cause hospitalization or death in patients with COVID-19 who are at high risk of progression to severe disease, regardless of anti-SARS-CoV-2 serostatus, according to a study presented at CROI 2022.
Sotrovimab reduces hospitalization, death in patients with COVID-19 regardless of serostatus
23 Mar 2022Pandemic contributes to poor mental, oral health
Oral health has been mildly compromised during the coronavirus disease 2019 (COVID-19) pandemic, particularly among people who have been infected and those suffering from depression, anxiety, and psychological stress, a recent study reported.
Pandemic contributes to poor mental, oral health
22 Mar 2022Age, medication use affect initial response to SARS-CoV-2 vaccines among IBD patients
Most patients with inflammatory bowel disease (IBD) build an initial immune response to SARS-CoV-2 vaccination, but older patients, those treated with antitumour necrosis factor (anti-TNF) and an immunomodulator, and those on corticosteroids may require an additional vaccine dose to achieve better immunity against COVID-19, according to a study.
Age, medication use affect initial response to SARS-CoV-2 vaccines among IBD patients
21 Mar 2022Oral antibiotics not inferior to IV-only therapy in blood, bone infections
Use of oral antibiotics in the treatment of osteomyelitis, bacteraemia, and infective endocarditis results in shorter hospital stay, has a better safety profile, and appears to be similarly effective when compared to intravenous (IV)-only therapy, a recent study has shown.